The landscape of gMG treatment is rapidly evolving, said John Morren, MD, of the Cleveland Clinic. The traditional approach ...

Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.

Imagine having to consider your health and its limitations every single day. Often, we take our health for granted, but ...

Last week Tuesday, PureTech had announced that Raju Kucherlapati stepped down immediately as chair and was replaced by Sharon Barber-Lui, who will be interim chair and also lead the process for ...

The drug came to AstraZeneca through its acquisition of CinCor Pharma in 2023, with the hopes of beefing up its ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

Vor Biopharma pivots to telitacicept with $175M funding, eyeing multi-billion potential. Risks include dilution, regulatory ...

THREE senators who are supporters of former president Rodrigo Duterte on Tuesday introduced a resolution compelling the ...

Three senators introduced a resolution compelling the Philippine government to advocate for the interim release of former ...

Senators Bong Go, Ronald dela Rosa and Robinhood Padilla have filed a resolution in the Senate, calling for the Philippine government to support their call for the interim release of former president ...

Fan favourite contestant Amina Elshafei has revealed that she has been privately suffering from a rare autoimmune condition. Read more.

In patients with myasthenia gravis (MG) who had anti-acetylcholine receptor antibodies or anti-muscle-specific kinase ...